Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
8.03
-0.17 (-2.07%)
Apr 17, 2026, 3:27 PM HKT
HKG:1167 Market Cap
HKG:1167 has a market cap or net worth of 6.44 billion as of April 16, 2026. Its market cap has increased by 139.99% in one year.
Market Cap
6.44B
Enterprise Value
5.36B
Revenue
59.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.03
Market Cap Chart
Since December 21, 2020, HKG:1167's market cap has decreased from 10.95B to 6.44B, a decrease of -41.24%. That is a compound annual growth rate of -9.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 6.44B | 28.38% |
| Dec 31, 2025 | 5.01B | 400.46% |
| Dec 31, 2024 | 1.00B | -65.05% |
| Dec 29, 2023 | 2.87B | -28.96% |
| Dec 30, 2022 | 4.03B | -63.93% |
| Dec 31, 2021 | 11.19B | 3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haohai Biological Technology | 9.32B |
| Abbisko Cayman | 9.12B |
| Laekna | 7.32B |
| CK Life Sciences Int'l., (Holdings) | 7.02B |
| Ocumension Therapeutics | 6.57B |
| Qyuns Therapeutics | 4.74B |
| Shandong Boan Biotechnology | 4.53B |
| Beijing Luzhu Biotechnology | 4.36B |